Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 312,332 | 254,844 | 861,312 | 356,409 | 444,568 |
| Marketable Securities | 682,401 | 1,280,833 | 1,553,409 | 360,330 | 300,286 |
| Receivables | N/A | N/A | N/A | 773,079 | N/A |
| TOTAL | $1,042,458 | $1,588,226 | $2,519,077 | $1,562,821 | $772,365 |
| Non-Current Assets | |||||
| PPE Net | 63,183 | 96,018 | 105,609 | 42,834 | 17,946 |
| Investments And Advances | 190,015 | 105,275 | 23,927 | 201,388 | 0 |
| Intangibles | 25,057 | 39,502 | 49,692 | 50,224 | 50,757 |
| Other Non-Current Assets | 78,100 | 90,039 | 103,783 | 97,001 | 77,693 |
| TOTAL | $356,355 | $330,834 | $283,011 | $391,447 | $146,396 |
| Total Assets | $1,398,813 | $1,919,060 | $2,802,088 | $1,954,268 | $918,761 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,081 | 6,334 | 6,422 | 6,521 | 5,077 |
| Accrued Expenses | 85,873 | 104,220 | 489,090 | 236,512 | 76,936 |
| Other current liabilities | 16,060 | N/A | N/A | N/A | 10,600 |
| TOTAL | $119,662 | $175,407 | $511,029 | $341,242 | $99,064 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,648 | 64,853 | 15,517 | 98,209 | 6,451 |
| Other Non-Current Liabilities | 128,766 | 153,473 | 159,889 | 158,923 | 95,777 |
| TOTAL | $128,766 | $153,417 | $213,096 | $181,177 | $102,845 |
| Total Liabilities | $248,428 | $328,824 | $724,125 | $522,419 | $201,909 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 137,143 | 135,032 | 133,531 | 132,304 | 127,837 |
| Common Shares | 14 | 13 | 13 | 13 | 13 |
| Retained earnings | -759,784 | -237,824 | 377,237 | -138,600 | -667,184 |
| Other shareholders' equity | -1,717 | -815 | -9,122 | -1,099 | -1,278 |
| TOTAL | $1,150,385 | $1,590,236 | $2,077,963 | $1,431,849 | $716,852 |
| Total Liabilities And Equity | $1,398,813 | $1,919,060 | $2,802,088 | $1,954,268 | $918,761 |